Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure

doi:10.4252/wjsc.v12.i4.277

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7983)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

508

WORD

119

HTML

4300

Figures (1-2)

241

Tables (1-4)

230

Sum=5398

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

374

Download

605

Sum=979

Publishing Process of This Article

Item

Count

Browse

615

Download

991

Sum=1606

Apr 26, 2020 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (32)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Stem Cells. Apr 26, 2020; 12(4): 277-287
Published online Apr 26, 2020. doi: 10.4252/wjsc.v12.i4.277

Full Size Figure Download Figure

Figure 2 Results of ovarian tissue staining (Haematoxylin-eosin staining). A: Negative control group; B: Model group; C: Human umbilical cord mesenchymal stem cells group; D: Positive control group (100×); E: Negative control group; F: Model group; G: Human umbilical cord mesenchymal stem cells group; H: Positive control group (200×).

Citation: Shen J, Cao D, Sun JL. Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure. World J Stem Cells 2020; 12(4): 277-287
URL: https://www.wjgnet.com/1948-0210/full/v12/i4/277.htm
DOI: https://dx.doi.org/10.4252/wjsc.v12.i4.277